Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

被引:23
|
作者
Inamori, Koji [1 ,2 ,3 ,4 ,5 ]
Togashi, Yosuke [1 ]
Fukuoka, Shota [1 ]
Akagi, Kiwamu [6 ]
Ogasawara, Kouetsu [7 ]
Irie, Takuma [1 ]
Motooka, Daisuke [8 ]
Kobayashi, Yoichi [9 ,10 ]
Sugiyama, Daisuke [9 ]
Kojima, Motohiro [11 ]
Shiiya, Norihiko [3 ,4 ,5 ]
Nakamura, Shota [8 ]
Maruyama, Shoichi [10 ]
Suzuki, Yutaka [12 ]
Ito, Masaaki [2 ]
Nishikawa, Hiroyoshi [1 ,9 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunol, Res Inst, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East NCCHE, Dept Colorectal Surg, Chiba, Japan
[3] Hamamatsu Univ, Div Cardiovasc, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ, Div Thorac, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Div Gen Endoscop & Breast Surg, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[6] Saitama Canc Ctr SCC, Div Mol Diag & Canc Prevent, Saitama, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan
[8] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan
[10] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan
[11] NCCHE, Div Pathol, Chiba, Japan
[12] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan
关键词
REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; PD-1; BLOCKADE; CLINICOPATHOLOGICAL FEATURES; EXPRESSION; TUMORS; COLON; INFILTRATION; MULTICENTER; IMMUNOLOGY;
D O I
10.1172/jci.insight.137365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers
    Wang, Zhenghang
    Cheng, Siyuan
    Yao, Yanhong
    Liu, Shengde
    Liu, Zimin
    Liu, Ning
    Jin, Yongdong
    Zhang, Yinjie
    Yin, Fei
    Han, Guangjie
    Zhang, Jingdong
    Wang, Qiwei
    Yan, Dong
    Wang, Li
    Lu, Hongxia
    Deng, Ting
    Ji, Zhi
    Gao, Hui
    Fang, Weijia
    Zhang, Hangyu
    Chen, Zhiyu
    Zou, Jianling
    Tang, Yong
    Xu, Chunlei
    Li, Jiayi
    Qu, Huajun
    Bao, Liying
    Cao, Baoshan
    Wang, Xicheng
    Xu, Ting
    Sun, Yu
    Shen, Lin
    Peng, Zhi
    Li, Jian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (09)
  • [42] Serial ctDNA monitoring during immunotherapy (IO) in patients (pts) with MSI-H/dMMR advanced colorectal cancer (CRC)
    Somer, B.
    Mehler, S.
    Greene, H.
    Tauer, K.
    Somer, S.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S123 - S123
  • [43] Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
    Oliveira, Andre F.
    Bretes, Luis
    Furtado, Irene
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [44] Clinical outcomes of immune checkpoint inhibitor (ICI) therapy among Veterans Affairs patients with colorectal cancer and discordant dMMR/MSI-H status.
    Isaacs, James
    Guo, Aixia
    Vashistha, Vishal
    Katsoulakis, Evangelia
    Boswell, Elizabeth
    Strickler, John H.
    Ahmed, Sara
    Kelley, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature
    San-Roman-Gil, Maria
    Martinez-Delfrade, Inigo
    Albarran-Fernandez, Victor
    Guerrero-Serrano, Patricia
    Pozas-Perez, Javier
    Chamorro-Perez, Jesus
    Rosero-Rodriguez, Diana
    Sotoca-Rubio, Pilar
    Barrill-Corpa, Ana Maria
    Alia-Navarro, Victor
    Gonzalez-Merino, Carlos
    Garcia-de-Quevedo-Suero, Coral
    Lopez, Victoria
    Ruz-Caracuel, Ignacio
    Perna-Monroy, Cristian
    Ferreiro-Monteagudo, Reyes
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
    Janindra Warusavitarne
    Margaret Schnitzler
    International Journal of Colorectal Disease, 2007, 22 : 739 - 748
  • [47] Is MSI-H of value in predicting the development of metachronous colorectal cancer?
    Lawes, DA
    Pearson, T
    SenGupta, S
    Boulos, PB
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) : 473 - 476
  • [48] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer
    Andre, Thierry
    Pietrantonio, Filippo
    Avallone, Antonio
    Gumus, Mahmut
    Wyrwicz, Lucjan
    Kim, Jong Gwang
    Yalcin, Suayib
    Kwiatkowski, Mariusz
    Lonardi, Sara
    Zolnierek, Jakub
    Odeleye-Ajakaye, Amos
    Leconte, Pierre
    Fogelman, David
    Kim, Tae Won
    FUTURE ONCOLOGY, 2023, 19 (37) : 2445 - 2452
  • [49] Neoadjuvant pembrolizumab shows promise in MSI-H/dMMR solid tumours
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (03) : 138 - 138
  • [50] Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
    Ambrosini, Margherita
    Manca, Paolo
    Nasca, Vincenzo
    Sciortino, Carolina
    Ghelardi, Filippo
    Seligmann, Jenny F.
    Taieb, Julien
    Pietrantonio, Filippo
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025,